Open AccessEffect of Homocysteine-Lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6on Clinical Outcome After Percutaneous Coronary Intervention
Author(s) -
Guido Schnyder,
Marco Roffi,
Yvonne Flammer,
Riccardo Pin,
Otto M. Hess
Publication year - 2002
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.288.8.973
Subject(s) - medicine , homocysteine , percutaneous coronary intervention , myocardial infarction , relative risk , placebo , adverse effect , clinical endpoint , cardiology , risk factor , restenosis , randomized controlled trial , rate ratio , confidence interval , gastroenterology , surgery , stent , pathology , alternative medicine
Plasma homocysteine level has been recognized as an important cardiovascular risk factor that predicts adverse cardiac events in patients with established coronary atherosclerosis and influences restenosis rate after percutaneous coronary intervention.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom